Samer Al Hadidi

Targets

• BCMA 1

Filled chips are declared by the researcher; the others come from publications (number of works).

Now

Trials, publications and grants since Nov 2024.

• Publication

  Peripheral blood immune cell profiling and response to BCMA CAR-T cell therapy in relapsed refractory multiple myeloma.

  Blood cancer journal, Jan 2026

• Publication

  Treatment of Multiple Myeloma: ASCO-Ontario Health (Cancer Care Ontario) Living Guideline.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Jan 2026

• Publication

  Inconsistent definitions of transplant ineligibility in multiple myeloma: A systematic review.

  British journal of haematology, Jan 2026

• Publication

  Talquetamab in relapsed refractory multiple myeloma: multi-institutional real-world study.

  Blood cancer journal, Nov 2025

• Publication

  Bispecific antibody therapy in CNS myeloma: Early evidence from a multicentre cohort.

  British journal of haematology, Aug 2025

Affiliations

• Harold C. Simmons Comprehensive Cancer Center
• University of Arkansas for Medical Sciences
• The University of Texas Southwestern Medical Center

Co-authors

Who links you

Enter another researcher's profile link or ID to see who has published with both of you.